Cointime

Biofourmis

company

About

Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics.

Highlights

Total Funding Amount
$463.50M S$100K
Funding Rounds
10
Investors
15
Acquisition
2
Employee Profiles
22

Details

Last Funding Type
Series D
Last Funding Money Raised
$300M
Industries
Biotechnology,mHealth,Personal Health,Predictive Analytics,Therapeutics
Founded date
Nov 27, 2015
Number Of Employee
101 - 250
Operating Status
Active
Legal Name
Biofourmis Inc
Also Known As
Biofourmis

Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. The company discovers, develops, and delivers clinically validated software-based therapeutics to enable better outcomes for patients. These solutions include advanced tools for clinicians to deliver personalized care and cost-effective solutions for payers.

Biofourmis was founded in 2015 and headquartered in Boston, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
10
$463.50M S$100K
Biofourmis has raised a total of $463.50M S$100K in funding over 2 rounds. Their latest funding was raised on Jul 27, 2022 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 27, 2022 Series D $20M 1 Intel Capital — Detail
Apr 26, 2022 Series D $300M 4 General Atlantic — Detail
Sep 3, 2020 Series C $100M 6 SoftBank Vision Fund — Detail
May 21, 2019 Series B $35M 7 MassMutual Ventures Southeast Asia (MMV SEA)
Sequoia Capital India 		— Detail
May 1, 2018 Series A $2M 2 — — Detail
Show More

Investors

Number of Lead Investors
Number of Investors
10
15
Biofourmis is funded by 15 investors. Intel Capital and General Atlantic are the most recent investors.
Investor Name Lead Investor Funding Round
Intel Capital Yes Series D
General Atlantic Yes Series D
SoftBank Vision Fund Yes Series C
Sequoia Capital India Yes Series B
SpesNet Pte. Ltd. Yes Seed
Eden Strategy Institute Yes Angel
CVS Health — Series D
EDBI — Series D
Openspace — Series D
Capikris Foundation — Series C
Show More

Employee Profiles

Number of Employee Profiles
22
Biofourmis has 22 current employee profiles, including Executive Ammar Darkazanli
Ammar Darkazanli
Executive
Wolfgang Werner
Employee
Trace Brookins
Executive
Wolfgang Werner
Executive
Andy Zucker
Executive
Show More

Acquisition

Biofourmis has acquired 2 organizations. Their most recent acquisition was Biovotion on Nov 19, 2019. They acquired Biovotion for 0.

Date Company Name
Industry Acquisition Type Price
Nov 19, 2019 Biovotion
Cloud Computing acquisition — Detail
Apr 16, 2020 Gaido Health
Artificial Intelligence acquisition — Detail
Cointime
Content
Company